RE: Analyst commentary….10 Mar 2022 08:14
Barclays: Overall, the brief trading update is fairly uneventful and we look to FY results on 4th May for more colour on the FY23 outlook. There is little incrementally new here – returns remain high as product mix normalizes, and international delivery times continue to impact. We still think there is downside to FY23 numbers, but there is little to change the debate in either direction today. We are UW Boohoo as we think it can continue to grow, but 1) short term it faces the most severe headwinds of peers (especially its international business), and 2) longer term, growth will come at a higher cost than MT guidance implies. Headline multiples look cheap at ~9x EV/EBITDA+1 but we see risks to estimates (they could get worse before they get better) and model –ve FCF for several years while capex is higher.
Jefferies: Jefferies analyst Andrew Wade says pressures facing co. are almost entirely transitory, rather than structural. Shares will end up having looked very cheap at these levels; looks for them to “regain some ground” today
Liberum: While we continue to believe in boohoo’s long-term potential and see a path for recovery to the medium-term growth targets it will be a long road. On valuation ground we are a Buy, but as a team we were torn with near term catalysts absent. Trading at only 0.4x 12m forward EV/sales (vs. 2.5x pre[1]pandemic) and 6x EV/EBITDA, we think the shares offer good long-term value. While current growth and margin dynamics suggest rating on boohoo should be HOLD, we think the shares look oversold and hence remain a BUY. To justify the current share price, we will have to model in our DCF that EBITDA margin remains in the 6-8% range permanently with sales growth at a 12% CAGR over next 5 years vs. the company targets of 9.5-10% EBITDA margin and 20-25% growth in the medium term.